PT2404906E - Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa - Google Patents
Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa Download PDFInfo
- Publication number
- PT2404906E PT2404906E PT111838538T PT07183853T PT2404906E PT 2404906 E PT2404906 E PT 2404906E PT 111838538 T PT111838538 T PT 111838538T PT 07183853 T PT07183853 T PT 07183853T PT 2404906 E PT2404906 E PT 2404906E
- Authority
- PT
- Portugal
- Prior art keywords
- inhibitor
- factor
- methods
- pharmaceutical salts
- synthesizing pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/90—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having more than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86414506P | 2006-11-02 | 2006-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2404906E true PT2404906E (pt) | 2015-11-02 |
Family
ID=39167635
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT111838538T PT2404906E (pt) | 2006-11-02 | 2007-11-01 | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa |
PT07863800T PT2077995E (pt) | 2006-11-02 | 2007-11-01 | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT07863800T PT2077995E (pt) | 2006-11-02 | 2007-11-01 | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa |
Country Status (10)
Country | Link |
---|---|
US (2) | US8524907B2 (pt) |
EP (2) | EP2077995B1 (pt) |
CN (1) | CN101595092B (pt) |
AT (1) | ATE544749T1 (pt) |
AU (1) | AU2007317376B2 (pt) |
CA (1) | CA2667488C (pt) |
ES (2) | ES2382055T3 (pt) |
HK (2) | HK1133258A1 (pt) |
PT (2) | PT2404906E (pt) |
WO (1) | WO2008057972A1 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696352B2 (en) * | 2004-06-18 | 2010-04-13 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
JP5227178B2 (ja) | 2005-11-08 | 2013-07-03 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | N−(5−クロロ−2−ピリジニル)−2−[[4−[(ジメチルアミノ)イミノメチル]ベンゾイル]アミノ]−5−メトキシ−ベンズアミド、第Xa因子阻害剤の薬学的な塩および多形体 |
EA015942B1 (ru) | 2006-05-05 | 2011-12-30 | Милленниум Фамэсьютикэлс, Инк. | Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови |
ES2382055T3 (es) * | 2006-11-02 | 2012-06-04 | Millennium Pharmaceuticals, Inc. | Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa |
EP2591783A1 (en) | 2007-04-13 | 2013-05-15 | Millennium Pharmaceuticals, Inc. | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
US8530501B2 (en) * | 2009-12-17 | 2013-09-10 | Millennium Pharmaceuticals, Inc. | Salts and crystalline forms of a factor Xa inhibitor |
US8742120B2 (en) * | 2009-12-17 | 2014-06-03 | Millennium Pharmaceuticals, Inc. | Methods of preparing factor xa inhibitors and salts thereof |
JP5766204B2 (ja) | 2009-12-17 | 2015-08-19 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 第Xa因子阻害剤の合成方法 |
AR082804A1 (es) | 2010-09-01 | 2013-01-09 | Portola Pharm Inc | Formas cristalinas de un inhibidor del factor xa |
US9200268B2 (en) | 2012-12-27 | 2015-12-01 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
US20140346397A1 (en) | 2012-12-27 | 2014-11-27 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
CN104341343B (zh) * | 2013-07-24 | 2018-09-28 | 四川海思科制药有限公司 | 贝曲西班的晶型及其制备方法和用途 |
CN104693114B (zh) * | 2013-12-10 | 2019-08-16 | 四川海思科制药有限公司 | 一种贝曲西班的改进的制备方法 |
CN105085387A (zh) * | 2014-05-20 | 2015-11-25 | 四川海思科制药有限公司 | 贝曲西班盐及其制备方法和用途 |
EP3078378B1 (en) | 2015-04-08 | 2020-06-24 | Vaiomer | Use of factor xa inhibitors for regulating glycemia |
WO2017091757A1 (en) | 2015-11-24 | 2017-06-01 | Portola Pharmaceuticals, Inc. | Isotopically enriched betrixaban |
CN105348187B (zh) * | 2015-12-02 | 2017-12-08 | 安徽省逸欣铭医药科技有限公司 | 一种贝曲西班结构类似物及其制备方法和用途 |
CN105732490A (zh) * | 2016-03-25 | 2016-07-06 | 重庆医科大学 | 一种贝曲西班的制备方法 |
EP3293174A1 (en) * | 2016-09-09 | 2018-03-14 | Sandoz Ag | Crystalline salts of betrixaban |
WO2018229796A2 (en) * | 2017-06-14 | 2018-12-20 | Mylan Laboratories Limited | A process for betrixaban hydrochloride and betrixaban maleate salt |
CN108570003A (zh) * | 2018-06-01 | 2018-09-25 | 浙江宏元药业股份有限公司 | 一种贝曲西班马来酸盐的一水无定形及其制备方法 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2095619A (en) * | 1937-10-12 | Aryl oxides | ||
CH428747A (de) | 1961-09-11 | 1967-01-31 | Wander Ag Dr A | Verfahren zur Herstellung neuer Harnstoff- und Thioharnstoffderivate |
GB1047245A (pt) | 1963-02-15 | |||
GB2095239B (en) * | 1981-02-27 | 1985-03-06 | Torii & Co Ltd | Novel amidine compounds |
US4500714A (en) | 1981-10-15 | 1985-02-19 | Chugai Seiyaku Kabushiki Kaisha | 3-Substituted-ureido-N-pyridyl benzamides |
US4588587A (en) * | 1983-03-01 | 1986-05-13 | Pennsylvania Hospital | Method of treatment to inhibit metastasis |
JPS59181257A (ja) | 1983-03-31 | 1984-10-15 | Chugai Pharmaceut Co Ltd | ウレイドベンズアミド誘導体 |
JP2668231B2 (ja) * | 1987-12-29 | 1997-10-27 | 大日精化工業株式会社 | 電子写真感光体 |
AU606808B2 (en) * | 1988-06-29 | 1991-02-14 | Otsuka Pharmaceutical Factory, Inc. | Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same |
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
US5612360A (en) * | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
WO1994013693A1 (en) | 1992-12-15 | 1994-06-23 | Corvas International, Inc. | NOVEL INHIBITORS OF FACTOR Xa |
GB9226238D0 (en) | 1992-12-16 | 1993-02-10 | Scherer Ltd R P | Encapsulation apparatus and process |
US5610335A (en) | 1993-05-26 | 1997-03-11 | Cornell Research Foundation | Microelectromechanical lateral accelerometer |
PT798295E (pt) | 1994-12-02 | 2003-07-31 | Yamanouchi Pharma Co Ltd | Novo derivado de amidinonaftilo ou sal deste |
EP0742208A1 (en) * | 1995-05-05 | 1996-11-13 | Grelan Pharmaceutical Co., Ltd. | 2-Ureido-benzamide derivatives |
US5849759A (en) | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
US5994375A (en) | 1996-02-12 | 1999-11-30 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
JP2000516234A (ja) | 1996-08-16 | 2000-12-05 | デュポン ファーマシューティカルズ カンパニー | アミジノフェニル―ピロリジン類、アミジノフェニル―ピロリン類、およびアミジノフェニル―イソオキサゾリジン類およびそれらの誘導体 |
AU4261697A (en) | 1996-09-09 | 1998-03-26 | Smithkline Beecham Corporation | Compounds and methods |
WO1998028269A1 (en) | 1996-12-23 | 1998-07-02 | Du Pont Pharmaceuticals Company | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
AU6645998A (en) | 1996-12-23 | 1998-07-17 | Du Pont Pharmaceuticals Company | Oxygen or sulfur containing heteroaromatics as factor xa inhibitors |
AU7976998A (en) | 1997-06-19 | 1999-01-04 | Du Pont Merck Pharmaceutical Company, The | (amidino)6-membered aromatics as factor xa inhibitors |
JP2002510313A (ja) | 1997-06-26 | 2002-04-02 | イーライ・リリー・アンド・カンパニー | 抗血栓物質 |
EP0999834B1 (en) | 1997-06-26 | 2005-10-12 | Eli Lilly And Company | Antithrombotic agents |
DE69830504T2 (de) | 1997-06-26 | 2006-03-16 | Eli Lilly And Co., Indianapolis | Antithrombotische mitteln |
CA2294042A1 (en) | 1997-06-26 | 1999-01-07 | David Kent Herron | Antithrombotic agents |
US5919779A (en) | 1997-08-11 | 1999-07-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,6-Heteroaryl-dipyrido(2,3-B:3', 2'-F) azepines and their use in the prevention or treatment of HIV infection |
WO1999010316A1 (fr) | 1997-08-27 | 1999-03-04 | Kissei Pharmaceutical Co., Ltd. | Derives de 3-amidinoaniline, inhibiteurs du facteur x de coagulation sanguine activee, et intermediaires de production de ces derives et de ces inhibiteurs |
US6140351A (en) * | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
IL135536A0 (en) | 1997-12-19 | 2001-05-20 | Schering Ag | Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same |
EP0937711A1 (de) | 1998-02-18 | 1999-08-25 | Roche Diagnostics GmbH | Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
JPH11302177A (ja) | 1998-04-27 | 1999-11-02 | Otsuka Pharmaceut Factory Inc | 腎炎治療剤 |
WO2000034258A2 (en) | 1998-12-09 | 2000-06-15 | American Home Products Corporation | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
JP2002531544A (ja) | 1998-12-09 | 2002-09-24 | ワイス | アセトアミド及び置換されたアセトアミドを含有するヘルペスウイルスのチオ尿素インヒビター |
CN1367785A (zh) | 1998-12-09 | 2002-09-04 | 美国家庭用品有限公司 | 含取代的苯二胺基团的含杂环羧酰胺的疱疹病毒硫脲抑制剂 |
ATE272052T1 (de) | 1998-12-09 | 2004-08-15 | Wyeth Corp | Thioharnstoff-inhibitoren von herpes-virus |
EP1137647A1 (en) | 1998-12-09 | 2001-10-04 | American Home Products Corporation | Thiourea inhibitors of herpes viruses |
WO2000034260A2 (en) | 1998-12-09 | 2000-06-15 | American Home Products Corporation | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
WO2000034269A1 (en) | 1998-12-09 | 2000-06-15 | American Home Products Corporation | Thiourea inhibitors of herpes viruses |
WO2000039118A1 (en) | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | Aromatic amides |
NZ517829A (en) | 1999-09-17 | 2004-12-24 | Millennium Pharm Inc | Benzamides and related inhibitors of factor Xa |
US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
US6844367B1 (en) * | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
US6720317B1 (en) * | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
WO2001064642A2 (en) * | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
AU776053B2 (en) * | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
SI1309555T1 (sl) * | 2000-12-29 | 2005-12-31 | Pfizer Ltd | Postopek izdelave amlodipin-maleata |
US7312235B2 (en) * | 2001-03-30 | 2007-12-25 | Millennium Pharmaceuticals, Inc. | Benzamide inhibitors of factor Xa |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
ES2338881T3 (es) * | 2003-10-09 | 2010-05-13 | Millennium Pharmaceuticals, Inc. | Benzamidas sustituidas con tioeter como inhibidores del factor xa. |
US7696352B2 (en) * | 2004-06-18 | 2010-04-13 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
KR101195801B1 (ko) * | 2004-06-18 | 2012-11-05 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Xa 인자 억제제 |
JP5227178B2 (ja) * | 2005-11-08 | 2013-07-03 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | N−(5−クロロ−2−ピリジニル)−2−[[4−[(ジメチルアミノ)イミノメチル]ベンゾイル]アミノ]−5−メトキシ−ベンズアミド、第Xa因子阻害剤の薬学的な塩および多形体 |
WO2007112367A2 (en) * | 2006-03-27 | 2007-10-04 | Portola Pharmaceuticals, Inc. | Potassium channel modulators and platelet procoagulant activity |
EA015942B1 (ru) * | 2006-05-05 | 2011-12-30 | Милленниум Фамэсьютикэлс, Инк. | Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови |
ES2382055T3 (es) * | 2006-11-02 | 2012-06-04 | Millennium Pharmaceuticals, Inc. | Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa |
KR101472765B1 (ko) * | 2006-12-08 | 2014-12-15 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 경구용 Xa 인자 억제제를 포함하는 단위 용량 제형 및 경구용 Xa 인자 억제제를 사용하는 혈전증의 치료 방법 |
JP2010515691A (ja) * | 2007-01-05 | 2010-05-13 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 第Xa因子阻害剤 |
EP2591783A1 (en) * | 2007-04-13 | 2013-05-15 | Millennium Pharmaceuticals, Inc. | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
PT2146705E (pt) * | 2007-05-02 | 2014-05-23 | Portola Pharm Inc | Terapia de combinação com um composto que atua como inibidor do recetor de adp de plaquetas |
JP5766204B2 (ja) * | 2009-12-17 | 2015-08-19 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 第Xa因子阻害剤の合成方法 |
-
2007
- 2007-11-01 ES ES07863800T patent/ES2382055T3/es active Active
- 2007-11-01 EP EP07863800A patent/EP2077995B1/en active Active
- 2007-11-01 CN CN2007800399575A patent/CN101595092B/zh active Active
- 2007-11-01 WO PCT/US2007/083394 patent/WO2008057972A1/en active Application Filing
- 2007-11-01 CA CA2667488A patent/CA2667488C/en not_active Expired - Fee Related
- 2007-11-01 AT AT07863800T patent/ATE544749T1/de active
- 2007-11-01 ES ES11183853.8T patent/ES2550057T3/es active Active
- 2007-11-01 PT PT111838538T patent/PT2404906E/pt unknown
- 2007-11-01 AU AU2007317376A patent/AU2007317376B2/en not_active Ceased
- 2007-11-01 US US12/446,954 patent/US8524907B2/en active Active
- 2007-11-01 PT PT07863800T patent/PT2077995E/pt unknown
- 2007-11-01 EP EP11183853.8A patent/EP2404906B1/en active Active
-
2010
- 2010-01-11 HK HK10100268.3A patent/HK1133258A1/xx not_active IP Right Cessation
-
2012
- 2012-06-29 HK HK12106397.2A patent/HK1165426A1/xx not_active IP Right Cessation
-
2013
- 2013-08-08 US US13/962,819 patent/US9221758B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9221758B2 (en) | 2015-12-29 |
US20100197929A1 (en) | 2010-08-05 |
WO2008057972A1 (en) | 2008-05-15 |
AU2007317376B2 (en) | 2013-01-17 |
EP2077995B1 (en) | 2012-02-08 |
PT2077995E (pt) | 2012-05-10 |
US20140046071A1 (en) | 2014-02-13 |
CN101595092A (zh) | 2009-12-02 |
ES2550057T3 (es) | 2015-11-04 |
CA2667488C (en) | 2015-07-07 |
ATE544749T1 (de) | 2012-02-15 |
ES2382055T3 (es) | 2012-06-04 |
EP2404906A1 (en) | 2012-01-11 |
CN101595092B (zh) | 2012-02-01 |
US8524907B2 (en) | 2013-09-03 |
EP2404906B1 (en) | 2015-07-15 |
AU2007317376A1 (en) | 2008-05-15 |
HK1133258A1 (en) | 2010-03-19 |
CA2667488A1 (en) | 2008-05-15 |
HK1165426A1 (en) | 2012-10-05 |
EP2077995A1 (en) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1165426A1 (en) | Methods of synthesizing pharmaceutical salts of a factor xa inhibitor xa | |
TNSN08407A1 (en) | Organic compounds | |
WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
NZ592497A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
CY1111671T1 (el) | Ετεροκυκλικη ενωση | |
WO2010014930A3 (en) | Piperidine derivatives as jak3 inhibitors | |
ME01992B (me) | Jedinjenje diarilhidantoina | |
NO20084783L (no) | Syntese av acylaminoalkenylenamider nyttige som substans P antagonister | |
RS53292B (en) | CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR | |
NZ592533A (en) | METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR | |
HK1153739A1 (en) | Spirocyclic derivatives as histone deacetylase inhibitors | |
WO2005074603A3 (en) | Aminobenzoxazoles as therapeutic agents | |
EA200801381A1 (ru) | Производные пиримидина | |
RS53503B1 (en) | AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR | |
DE602005019316D1 (en) | Aromatische etherderivate als thrombin-hemmer | |
DE602005016297D1 (de) | Antithrombotische diamide | |
MX2009012125A (es) | Compuestos terapeuticos. | |
EA201170617A1 (ru) | Пиразолиламинопиридины в качестве ингибиторов fak | |
AU2008303600A8 (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
WO2009154754A3 (en) | Synthesis of deuterated morpholine derivatives | |
PT2049480E (pt) | Derivados de 2-arilindole como inibidores da mpges-i | |
MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
ECSP11011081A (es) | 3-aminociclopentancarboxamidas | |
ZA201007603B (en) | Therapeutic compounds | |
IN2014DN04588A (pt) |